Safety and Efficacy Study of Zilucoplan in Subjects With Immune-Mediated Necrotizing Myopathy
Clinical trial NCT04025632 · TERMINATED
Trial details
- NCT number
- NCT04025632
- Sponsor
- Ra Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-07
- Primary completion
- 2021-03-04
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.